subscribeSubscribe
price-trendAsk Us
Ligand to Acquire APEIRON Biologics AG for $100 Million

Ligand to Acquire APEIRON Biologics AG for $100 Million
BUSINESSWIRE
08 Jul 2024
Share Share
BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.

BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.
BUSINESSWIRE
17 Aug 2021
Share Share
EUSA Pharma and BeiGene Announce Acceptance of a BLA for QARZIBA

EUSA Pharma and BeiGene Announce Acceptance of a BLA for QARZIBA
BUSINESSWIRE
09 Nov 2020
Share Share
United Therap`s Biological Dinutuximab Receives Approval In US

United Therap`s Biological Dinutuximab Receives Approval In US
FDA
29 Sep 2020
Share Share
United Therapeutics Announces Study of Unituxin® for Small Cell Lung Cancer

United Therapeutics Announces Study of Unituxin® for Small Cell Lung Cancer
PR NEWSWIRE
03 Feb 2020
Share Share
SMC endorses EUSA Pharma’s Qarziba

SMC endorses EUSA Pharma’s Qarziba
Selina McKee PHARMA TIMES
13 Nov 2018
Share Share
Y-mAbs preps $92M IPO to push lead assets through regulatory filing

Y-mAbs preps $92M IPO to push lead assets through regulatory filing
Amirah Al Idrus FIERCE BIOTECH
28 Aug 2018
Share Share
EUSA Pharma: NICE approves QARZIBA (dinutuximab beta) for neuroblastoma

EUSA Pharma: NICE approves QARZIBA (dinutuximab beta) for neuroblastoma
BUSINESSWIRE
14 Jul 2018
Share Share